2020 tables: Institutions - Nature & Science - corporate

The 2020 tables are based on Nature Index data from 1 January 2019 to 31 December 2019.

Table criteria

Request a badge Export CSV
# Institution Share 2018 Share 2019 Count 2019 Change in Adjusted Share* 2018–2019
1 F. Hoffmann-La Roche AG, Switzerland 5.01 5.27 12 5.4%
2 IBM Corporation, United States of America (USA) 4.16 4.73 12 14.1%
3 Alphabet Inc., United States of America (USA) 4.88 3.83 8 -21.3%
4 Novartis International AG, Switzerland 1.93 2.93 11 52.3%
5 Merck & Co., Inc., United States of America (USA) 4.43 1.94 8 -56.0%
6 Amgen Inc., United States of America (USA) 1.38 1.69 3 22.5%
7 Toyota Group, Japan – 1.40 2 N/A
8 Grillo-Werke AG, Germany – 1.00 1 N/A
9 Bristol-Myers Squibb (BMS), United States of America (USA) 0.93 0.98 3 4.8%
10 Johnson & Johnson, United States of America (USA) 0.69 0.86 1 25.8%
11 Arbor Biotechnologies, Inc., United States of America (USA) – 0.83 1 N/A
12 Samsung Group, South Korea 0.63 0.81 3 28.5%
13 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 1.87 0.74 6 -60.1%
14 Pfizer Inc., United States of America (USA) 1.48 0.60 5 -59.5%
15 Polyphor Ltd., Switzerland – 0.53 1 N/A
16 Microsoft Corporation, United States of America (USA) 0.04 0.51 4 1242.1%
17 AstraZeneca plc, United Kingdom (UK) 0.55 0.50 4 -8.8%
18 Nimbus Therapeutics, United States of America (USA) – 0.50 1 N/A
19 Novo Nordisk A/S, Denmark 0.14 0.49 2 263.9%
20 Sanofi, France 0.06 0.48 4 662.9%
21 BGI, China 0.52 0.46 7 -11.5%
22 Leidos Holdings, Inc., United States of America (USA) 0.31 0.43 8 40.7%
23 GNS Science, New Zealand – 0.36 3 N/A
24 Thermo Fisher Scientific Inc., United States of America (USA) 0.04 0.34 3 725.5%
25 Semma Therapeutics, Inc., United States of America (USA) – 0.33 1 N/A
25 Haldor Topsøe A/S, Denmark – 0.33 1 N/A
26 Cambridge Display Technology Ltd., United Kingdom (UK) – 0.31 1 N/A
27 Schrödinger, LLC, United States of America (USA) – 0.31 2 N/A
28 Nion Company, United States of America (USA) – 0.30 1 N/A
29 Illumina, Inc., United States of America (USA) 0.35 0.30 3 -14.9%
30 Firebird Biomolecular Sciences, LLC, United States of America (USA) – 0.28 1 N/A
31 Crystalline Mirror Solutions GmbH, Austria – 0.27 1 N/A
32 Electromagnetic Geoservices ASA (EMGS), Norway – 0.25 1 N/A
32 Meta Platforms, Inc., United States of America (USA) – 0.25 1 N/A
32 Murata Manufacturing Co., Ltd., Japan – 0.25 1 N/A
32 Dottikon Exclusive Synthesis AG, Switzerland – 0.25 1 N/A
33 ConfometRx, United States of America (USA) – 0.24 1 N/A
34 Anglo American plc, United Kingdom (UK) 0.48 0.22 1 -53.6%
35 Aduro BioTech, Inc., United States of America (USA) 0.02 0.22 2 997.7%
36 Analog Devices, Inc. (ADI), United States of America (USA) – 0.21 1 N/A
37 Dyno Therapeutics, Inc., United States of America (USA) – 0.21 1 N/A
38 Sosei Co., Ltd., Japan 1.00 0.20 1 -79.9%
38 The MathWorks, Inc., United States of America (USA) – 0.20 1 N/A
38 AbbVie Inc., United States of America (USA) 0.07 0.20 1 180.9%
38 Argenx SE, Belgium 0.25 0.20 1 -19.7%
38 TRS Technologies, Inc., United States of America (USA) – 0.20 1 N/A
39 10x Genomics, United States of America (USA) – 0.19 3 N/A
40 KinetX Aerospace, Inc., United States of America (USA) – 0.19 2 N/A
41 MedGenome Labs Pvt Ltd., India – 0.19 1 N/A
42 SDS Biotech K.K., Japan – 0.19 1 N/A
42 DNA Software Inc., United States of America (USA) – 0.19 1 N/A
43 ICF International, Inc., United States of America (USA) 0.13 0.18 2 48.0%
44 Bayer AG, Germany 0.11 0.18 3 61.1%
45 Guangzhou Wolbaki Biotech Co., Ltd., China – 0.17 1 N/A
46 Codexis, Inc., United States of America (USA) – 0.17 1 N/A
47 Qi's Academy, China – 0.17 1 N/A
47 Curt-Engelhorn-Centre Archaeometry gGmbH, Germany – 0.17 1 N/A
47 JEOL Ltd., Japan 0.05 0.17 1 234.4%
47 Science Systems and Applications, Inc. (SSAI), United States of America (USA) – 0.17 1 N/A
48 Bruker Corporation, United States of America (USA) 0.10 0.16 2 60.3%
49 Enamine Ltd., Ukraine – 0.16 2 N/A
50 EpiCypher, Inc., United States of America (USA) – 0.16 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.